JHEQX
Price
$35.87
Change
+$0.47 (+1.33%)
Updated
Sep 21 closing price
Net Assets
17.87B
JHQCX
Price
$35.31
Change
+$0.45 (+1.29%)
Updated
Sep 21 closing price
Net Assets
17.87B
Interact to see
Advertisement

JHEQX vs JHQCX

JHEQX vs JHQCX Comparison Chart in %
View a ticker or compare two or three
VS
JHEQX vs. JHQCX commentary
Sep 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JHEQX is a Hold and JHQCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JHEQX (17.9B) and JHQCX (17.9B) have equal amount of cash in the bank . JHEQX pays higher dividends than JHQCX: JHEQX (0.55) vs JHQCX (0.01). JHEQX was incepted earlier than JHQCX: JHEQX (13 years) vs JHQCX (13 years). JHQCX (1.32) is less costly to investors than JHEQX (0.57). JHEQX (27.00) and JHQCX (27.00) have comparable annual turnover. JHQCX has a lower initial minimum investment than JHEQX: JHQCX (1000) vs JHEQX (1000000). JHEQX annual gain was more profitable for investors over the last year : 2.98 vs. JHQCX (2.21). JHEQX return over 5 years is better than : 37.99 vs. JHQCX (33.87).
JHEQXJHQCXJHEQX / JHQCX
Total Expense Ratio0.571.3243%
Annual Report Gross Expense Ratio0.571.3243%
Fund Existence13 years13 years-
Gain YTD0.329-0.172-192%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets17.9B17.9B100%
Annual Yield % from dividends0.550.017,503%
Returns for 1 year2.982.21135%
Returns for 3 years30.1027.19111%
Returns for 5 years37.9933.87112%
Returns for 10 years130.55116.79112%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGKCX33.610.29
+0.87%
PGIM Jennison Technology C
MUXAX30.920.05
+0.16%
Victory S&P 500 Index A
HBLTX14.97-0.05
-0.33%
Hartford Balanced Income R5
COVAX14.52-0.12
-0.82%
Columbia Sm Cp Val and Inflection A
FBTCX36.43-0.58
-1.57%
Fidelity Advisor Biotechnology C